Skip to main content
Top
Published in: Archives of Virology 11/2015

01-11-2015 | Original Article

A porcine circovirus-2 mutant isolated in Brazil contains low-frequency substitutions in regions of immunoprotective epitopes in the capsid protein

Authors: Rafael Locatelli Salgado, Pedro Marcus Pereira Vidigal, Natalia F. Gonzaga, Luiz F. L. de Souza, Marcelo D. Polêto, Thiago Souza Onofre, Monique R. Eller, Carlos Eduardo Real Pereira, Juliana L. R. Fietto, Gustavo C. Bressan, Roberto M. C. Guedes, Márcia R. Almeida, Abelardo Silva Júnior

Published in: Archives of Virology | Issue 11/2015

Login to get access

Abstract

Porcine circovirus-2 (PCV2) is the etiologic agent of several diseases in pigs, including multi-systemic wasting syndrome (PMWS). In this work, a new mutant PCV2b was isolated from PMWS-affected pigs on a Brazilian farm. Its genome showed high sequence similarity (>99 % identity) to those from a group of emerging mutants isolated from cases of PMWS outbreaks in vaccinated pigs in China, the USA and South Korea. Here, we show that these isolates share a combination of low-frequency substitutions (single amino acid polymorphisms with a frequency of ≤25 %) in the viral capsid protein, mainly in regions of immunoprotective epitopes, and an additional lysine residue at position 234. These isolates were phylogenetically grouped in the PCV2b clade, reinforcing the idea of the emergence of a new group of mutants PCV2b associated with outbreaks worldwide. The identification of these polymorphisms in the viral capsid highlights the importance of considering these isolates for the development of more-effective vaccines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Opriessnig T, Meng X-J, Halbur PG (2007) Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 19:591–615CrossRefPubMed Opriessnig T, Meng X-J, Halbur PG (2007) Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 19:591–615CrossRefPubMed
4.
8.
go back to reference Segalés J, Olvera A, Grau-Roma L, Charreyre C, Nauwynck H, Larsen L, Dupont K, McCullough K, Ellis J, Krakowka S, Mankertz A, Fredholm M, Fossum C, Timmusk S, Stockhofe-Zurwieden N, Beattie V, Armstrong D, Grassland B, Baekbo P, Allan G (2008) PCV-2 genotype definition and nomenclature. Vet Rec 162:867–868CrossRefPubMed Segalés J, Olvera A, Grau-Roma L, Charreyre C, Nauwynck H, Larsen L, Dupont K, McCullough K, Ellis J, Krakowka S, Mankertz A, Fredholm M, Fossum C, Timmusk S, Stockhofe-Zurwieden N, Beattie V, Armstrong D, Grassland B, Baekbo P, Allan G (2008) PCV-2 genotype definition and nomenclature. Vet Rec 162:867–868CrossRefPubMed
9.
go back to reference Fraile L, Sibila M, Nofrarías M, López-Jimenez R, Huerta E, Llorens A, López-Soria S, Pérez D, Segalés J (2012) Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters. Vet Microbiol 161:229–234. doi:10.1016/j.vetmic.2012.07.021 CrossRefPubMed Fraile L, Sibila M, Nofrarías M, López-Jimenez R, Huerta E, Llorens A, López-Soria S, Pérez D, Segalés J (2012) Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters. Vet Microbiol 161:229–234. doi:10.​1016/​j.​vetmic.​2012.​07.​021 CrossRefPubMed
10.
go back to reference Han K, Seo HW, Oh Y, Park C, Kang I, Jang H, Chae C (2013) Efficacy of a piglet-specific commercial inactivated vaccine against Porcine circovirus type 2 in clinical field trials. Can J Vet Res 77:237–240PubMedCentralPubMed Han K, Seo HW, Oh Y, Park C, Kang I, Jang H, Chae C (2013) Efficacy of a piglet-specific commercial inactivated vaccine against Porcine circovirus type 2 in clinical field trials. Can J Vet Res 77:237–240PubMedCentralPubMed
11.
go back to reference Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S, Caleffi A, Borghetti P (2011) One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 149:339–351. doi:10.1016/j.vetmic.2010.12.008 CrossRefPubMed Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S, Caleffi A, Borghetti P (2011) One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 149:339–351. doi:10.​1016/​j.​vetmic.​2010.​12.​008 CrossRefPubMed
12.
go back to reference Park C, Seo HW, Han K, Chae C (2014) Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex u. Clin Vaccine Immunol 21:399–406. doi:10.1128/CVI.00768-13 PubMedCentralCrossRefPubMed Park C, Seo HW, Han K, Chae C (2014) Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex u. Clin Vaccine Immunol 21:399–406. doi:10.​1128/​CVI.​00768-13 PubMedCentralCrossRefPubMed
13.
go back to reference Takahagi Y, Toki S, Nishiyama Y, Morimatsu F, Murakami H (2010) Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms. J Vet Med Sci 72:35–41CrossRefPubMed Takahagi Y, Toki S, Nishiyama Y, Morimatsu F, Murakami H (2010) Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms. J Vet Med Sci 72:35–41CrossRefPubMed
14.
go back to reference Opriessnig T, Gerber PF, Xiao C-T, Mogler M, Halbur PG (2014) A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain. Vaccine 32:230–237. doi:10.1016/j.vaccine.2013.11.010 CrossRefPubMed Opriessnig T, Gerber PF, Xiao C-T, Mogler M, Halbur PG (2014) A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain. Vaccine 32:230–237. doi:10.​1016/​j.​vaccine.​2013.​11.​010 CrossRefPubMed
15.
go back to reference Toplak I, Lazić S, Lupulović D, Prodanov-Radulović J, Becskei Z, Došen R (2012) Petrović T (2012) Study of the genetic variability of porcine circovirus type 2 detected in Serbia and Slovenia. Acta Vet Hung 60:409–420. doi:10.1556/AVet.035 CrossRefPubMed Toplak I, Lazić S, Lupulović D, Prodanov-Radulović J, Becskei Z, Došen R (2012) Petrović T (2012) Study of the genetic variability of porcine circovirus type 2 detected in Serbia and Slovenia. Acta Vet Hung 60:409–420. doi:10.​1556/​AVet.​035 CrossRefPubMed
17.
go back to reference Seo HW, Park C, Kang I, Choi K, Jeong J, Park SJ, Chae C (2014) Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea. Arch Virol. doi:10.1007/s00705-014-2164-6 Seo HW, Park C, Kang I, Choi K, Jeong J, Park SJ, Chae C (2014) Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea. Arch Virol. doi:10.​1007/​s00705-014-2164-6
18.
go back to reference Guo L, Fu Y, Wang Y, Lu Y, Wei Y, Tang Q, Fan P, Liu J, Zhang L, Zhang F, Huang L, Liu D, Li S, Wu H, Liu C (2012) A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain. PLoS One 7:e41463. doi:10.1371/journal.pone.0041463 PubMedCentralCrossRefPubMed Guo L, Fu Y, Wang Y, Lu Y, Wei Y, Tang Q, Fan P, Liu J, Zhang L, Zhang F, Huang L, Liu D, Li S, Wu H, Liu C (2012) A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain. PLoS One 7:e41463. doi:10.​1371/​journal.​pone.​0041463 PubMedCentralCrossRefPubMed
19.
go back to reference Salgado RL, Vidigal PMP, de Souza LFL, Onofre TS, Gonzaga NF, Eller MR, Bressan GC, Fietto JLR, Almeida MR, Silva Júnior A (2014) Identification of an emergent porcine circovirus-2 in vaccinated pigs from a Brazilian farm during a postweaning multisystemic wasting syndrome outbreak. Genome Announc. doi:10.1128/genomeA.00163-14 PubMedCentralPubMed Salgado RL, Vidigal PMP, de Souza LFL, Onofre TS, Gonzaga NF, Eller MR, Bressan GC, Fietto JLR, Almeida MR, Silva Júnior A (2014) Identification of an emergent porcine circovirus-2 in vaccinated pigs from a Brazilian farm during a postweaning multisystemic wasting syndrome outbreak. Genome Announc. doi:10.​1128/​genomeA.​00163-14 PubMedCentralPubMed
20.
go back to reference Segalés J, Rosell C, Domingo M (2004) Pathological findings associated with naturally acquired porcine circovirus type 2 associated disease. Vet Microbiol 98:137–149CrossRefPubMed Segalés J, Rosell C, Domingo M (2004) Pathological findings associated with naturally acquired porcine circovirus type 2 associated disease. Vet Microbiol 98:137–149CrossRefPubMed
21.
go back to reference Corrêa AMR, Pescador CA, Schmitz M, Zlotowski P, Rozza DB, Oliveira EC, Barcellos DE, Driemeier D (2006) Aspectos clínico-patológicos associados à circovirose suína no Rio Grande do Sul. Pesqui Veterinária Bras 26:9–13 Corrêa AMR, Pescador CA, Schmitz M, Zlotowski P, Rozza DB, Oliveira EC, Barcellos DE, Driemeier D (2006) Aspectos clínico-patológicos associados à circovirose suína no Rio Grande do Sul. Pesqui Veterinária Bras 26:9–13
22.
go back to reference Souza NN, Lobato ZIP, Guedes RMC (2008) Estudo retrospectivo de diagnóstico de circovirose suína pela técnica de imunohistoquímica. Arq Inst Biol (Sao Paulo) 75:521–525 Souza NN, Lobato ZIP, Guedes RMC (2008) Estudo retrospectivo de diagnóstico de circovirose suína pela técnica de imunohistoquímica. Arq Inst Biol (Sao Paulo) 75:521–525
24.
go back to reference Sorden SD, Harms PA, Nawagitgul P, Cavanaugh D, Paul PS (1999) Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue. J Vet Diagn Invest 11:528–530CrossRefPubMed Sorden SD, Harms PA, Nawagitgul P, Cavanaugh D, Paul PS (1999) Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue. J Vet Diagn Invest 11:528–530CrossRefPubMed
25.
go back to reference Vidigal PMP, Mafra CL, Silva FMF, Fietto JLR, Silva Júnior A, Almeida MR (2012) Tripping over emerging pathogens around the world: a phylogeographical approach for determining the epidemiology of Porcine circovirus-2 (PCV-2), considering global trading. Virus Res 163:320–327. doi:10.1016/j.virusres.2011.10.019 CrossRefPubMed Vidigal PMP, Mafra CL, Silva FMF, Fietto JLR, Silva Júnior A, Almeida MR (2012) Tripping over emerging pathogens around the world: a phylogeographical approach for determining the epidemiology of Porcine circovirus-2 (PCV-2), considering global trading. Virus Res 163:320–327. doi:10.​1016/​j.​virusres.​2011.​10.​019 CrossRefPubMed
28.
go back to reference Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696–704CrossRefPubMed Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696–704CrossRefPubMed
29.
30.
go back to reference Zwickl D (2006) Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. The University of Texas, Austin Zwickl D (2006) Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. The University of Texas, Austin
34.
go back to reference Eddicks M, Fux R, Szikora F, Eddicks L, Majzoub-Altweck M, Hermanns W, Sutter G, Palzer A, Banholzer E, Ritzmann M (2015) Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany. Vet Microbiol 176:337–343. doi:10.1016/j.vetmic.2015.01.013 CrossRefPubMed Eddicks M, Fux R, Szikora F, Eddicks L, Majzoub-Altweck M, Hermanns W, Sutter G, Palzer A, Banholzer E, Ritzmann M (2015) Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany. Vet Microbiol 176:337–343. doi:10.​1016/​j.​vetmic.​2015.​01.​013 CrossRefPubMed
35.
go back to reference Franzo G, Cortey M, De Castro AMMG, Piovezan U, Szabo MPJ, Drigo M, Segalés J, Richtzenhain LJ (2015) Genetic characterisation of Porcine circovirus type 2 (PCV2) strains from feral pigs in the Brazilian Pantanal: an opportunity to reconstruct the history of PCV2 evolution. Vet Microbiol 178:158–162. doi:10.1016/j.vetmic.2015.05.003 CrossRefPubMed Franzo G, Cortey M, De Castro AMMG, Piovezan U, Szabo MPJ, Drigo M, Segalés J, Richtzenhain LJ (2015) Genetic characterisation of Porcine circovirus type 2 (PCV2) strains from feral pigs in the Brazilian Pantanal: an opportunity to reconstruct the history of PCV2 evolution. Vet Microbiol 178:158–162. doi:10.​1016/​j.​vetmic.​2015.​05.​003 CrossRefPubMed
37.
39.
go back to reference Mahé D, Blanchard P, Truong C, Arnauld C, Le Cann P, Cariolet R, Madec F, Albina E, Jestin A (2000) Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J Gen Virol 81:1815–1824CrossRefPubMed Mahé D, Blanchard P, Truong C, Arnauld C, Le Cann P, Cariolet R, Madec F, Albina E, Jestin A (2000) Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J Gen Virol 81:1815–1824CrossRefPubMed
40.
go back to reference Truong C, Mahe D, Blanchard P, Le Dimna M, Madec F, Jestin A, Albina E (2001) Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch Virol 146:1197–1211CrossRefPubMed Truong C, Mahe D, Blanchard P, Le Dimna M, Madec F, Jestin A, Albina E (2001) Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch Virol 146:1197–1211CrossRefPubMed
41.
42.
go back to reference Fraile L, Grau-Roma L, Sarasola P, Sinovas N, Nofrarías M, López-Jimenez R, López-Soria S, Sibila M, Segalés J (2012) Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity. Vaccine 30:1986–1992. doi:10.1016/j.vaccine.2012.01.008 CrossRefPubMed Fraile L, Grau-Roma L, Sarasola P, Sinovas N, Nofrarías M, López-Jimenez R, López-Soria S, Sibila M, Segalés J (2012) Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity. Vaccine 30:1986–1992. doi:10.​1016/​j.​vaccine.​2012.​01.​008 CrossRefPubMed
44.
go back to reference Opriessnig T, Ramamoorthy S, Madson DM, Patterson AR, Pal N, Carman S, Meng XJ, Halbur PG (2008) Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. J Gen Virol 89:2482–2491. doi:10.1099/vir.0.2008/001081-0 CrossRefPubMed Opriessnig T, Ramamoorthy S, Madson DM, Patterson AR, Pal N, Carman S, Meng XJ, Halbur PG (2008) Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. J Gen Virol 89:2482–2491. doi:10.​1099/​vir.​0.​2008/​001081-0 CrossRefPubMed
45.
go back to reference Opriessnig T, Gerber PF, Xiao CT, Halbur PG, Matzinger SR, Meng XJ (2014) Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Vaccine 32:4342–4348. doi:10.1016/j.vaccine.2014.06.004 CrossRefPubMed Opriessnig T, Gerber PF, Xiao CT, Halbur PG, Matzinger SR, Meng XJ (2014) Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Vaccine 32:4342–4348. doi:10.​1016/​j.​vaccine.​2014.​06.​004 CrossRefPubMed
46.
go back to reference Chiarelli-Neto O, Yotoko KSC, Vidigal PMP, Silva FMF, Castro LA, Fietto JLR, Silva A, Almeida MR (2009) Classification and putative origins of Brazilian porcine circovirus 2 inferred through phylogenetic and phylogeographical approaches. Virus Res 140:57–63. doi:10.1016/j.virusres.2008.11.002 CrossRefPubMed Chiarelli-Neto O, Yotoko KSC, Vidigal PMP, Silva FMF, Castro LA, Fietto JLR, Silva A, Almeida MR (2009) Classification and putative origins of Brazilian porcine circovirus 2 inferred through phylogenetic and phylogeographical approaches. Virus Res 140:57–63. doi:10.​1016/​j.​virusres.​2008.​11.​002 CrossRefPubMed
Metadata
Title
A porcine circovirus-2 mutant isolated in Brazil contains low-frequency substitutions in regions of immunoprotective epitopes in the capsid protein
Authors
Rafael Locatelli Salgado
Pedro Marcus Pereira Vidigal
Natalia F. Gonzaga
Luiz F. L. de Souza
Marcelo D. Polêto
Thiago Souza Onofre
Monique R. Eller
Carlos Eduardo Real Pereira
Juliana L. R. Fietto
Gustavo C. Bressan
Roberto M. C. Guedes
Márcia R. Almeida
Abelardo Silva Júnior
Publication date
01-11-2015
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2015
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2567-z

Other articles of this Issue 11/2015

Archives of Virology 11/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.